AUS
NZ
UK
CA
USA
IND
Highlights
- Macquarie’s share price has risen by 37% in the past year.
- UBS has a neutral rating and a price target of $225, suggesting a potential decline.
- Macquarie is projected to make $17.4 billion in revenue and $9.66 EPS in FY25.
Macquarie Group Ltd (ASX:MQG) has experienced an extraordinary surge in its share price, climbing 37% over the past year. This rise has fueled optimism among investors, leading many to wonder whether the financial giant can continue this impressive performance into 2025. However, after such a significant rise, many experts caution that past performance may not be an accurate predictor of future success.
Impact of Economic Conditions
Macquarie is deeply integrated into both the local and global economies, and its operations have been influenced by the broader economic environment, particularly the challenges posed by high inflation and rising interest rates. While the bank has shown resilience in these uncertain times, analysts are becoming more cautious. Despite its strong historical performance, there are concerns that Macquarie’s short-term growth potential might be limited after its recent rise.
Expert Insights and Predictions for 2025
UBS, a leading broker, has issued a neutral rating on Macquarie’s shares. They have set a price target of $225, which implies a potential decline of over 3% from the current price level. This suggests that UBS believes Macquarie’s stock has likely peaked for now, as the market has already priced in much of the optimism surrounding the company. While the broker maintains a neutral stance, there is still potential for the market to become even more optimistic, driving the stock price higher.
Weaker-than-Expected FY25 Results
UBS pointed out that Macquarie's first-half FY25 results were weaker than expected, primarily due to a disappointing performance from the Commodities and Global Markets (CGM) division. This was mainly driven by commodity risk management issues. Additionally, delays in asset sales and realizations further compounded the weaker-than-expected performance.
Following these results, UBS downgraded its earnings forecasts for Macquarie in the near term. While analysts have generally been reducing profit expectations, the share price remains close to an all-time high, raising questions about its valuation relative to future earnings potential.
Investment Case and Market Sentiment
UBS emphasized that Macquarie’s investment case continues to depend on asset realizations, capital deployment, and performance fees, especially within Macquarie Asset Management (MAM). Investors are also closely watching the sustainability of profits within the CGM division and any improvements in capital market activity that could benefit Macquarie Capital (MacCap).
Despite some concerns, the market remains optimistic about Macquarie’s long-term prospects, with the company’s stock trading above historical levels. However, the elevated price levels present challenges for investors considering the potential risks in the near term.
FY25 Financial Projections
Looking ahead to FY25, analysts are projecting that Macquarie will generate $17.4 billion in revenue, $5 billion in pre-tax profit, and $3.64 billion in net profit. This equates to an estimated earnings per share (EPS) of $9.66. If these projections hold true, the Macquarie share price would be valued at 24 times the company’s estimated FY25 earnings, suggesting that the stock is priced at a premium relative to its future earnings.
